Health CanadaGeneral Alert
Skin-cancer drug Zelboraf (vemurafenib): new warning on the risk of pancreatitis
Published: February 12, 2015Recall ID: 53051Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information - Product safety
Product Description & Identification
Skin-cancer drug Zelboraf (vemurafenib): new warning on the risk of pancreatitis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 53051 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/skin-cancer-drug-zelboraf-vemurafenib-new-warning-risk-pancreatitis |
| Issue | New safety information - Product safety |
| Title | Skin-cancer drug Zelboraf (vemurafenib): new warning on the risk of pancreatitis |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2015-02-12 |
| Organization | Communications and Public Affairs Branch |